Dead-end pages

Jump to navigation Jump to search

The following pages do not link to other pages in QIBA Wiki.

Showing below up to 50 results in range #11 to #60.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. About QIBA
  2. Additional letters of support can be found here
  3. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  4. Alzheimer's Disease PET Archive
  5. Ambition Levels for Collaboration
  6. Archive
  7. Archive - Lung Density
  8. Archived: 2009 COPD/Asthma Call Summaries
  9. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  10. Archived: 2010 COPD/Asthma Call Summaries
  11. Archived: 2011 COPD/Asthma Call Summaries
  12. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  13. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  14. Archived: 2012 QIBA US SWS Technical Committee call summaries
  15. Archived: 2012 fMRI Reproducibility Call Summaries
  16. Archived: 2013 fMRI Bias WG Call Summaries
  17. Archived: 2014 fMRI Bias WG Call Summaries
  18. Archived: 2016 Lung Density BC Call Summaries
  19. Archived: fMRI Bias WG Call Summaries
  20. Archived: fMRI Reproducibility Call Summaries
  21. Archived "What is a Profile?" description as of 08.19.2011
  22. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  23. Archived - 2011 fMRI Reproducibility Call Summaries
  24. Archived DCE-MRI Profiles
  25. Archived Versions of QIBA Vol CT - Group 3A draft documents
  26. Atherosclerosis Biomarkers Profile Draft Archive
  27. Atherosclerosis Biomarkers by CTA, Clinically Feasible Profile
  28. Atherosclerosis Biomarkers by CTA, Clinically Feasible Profile 2024June
  29. CEUS BC Call Summaries
  30. CEUS Task Force (TF) Call Summaries
  31. COPD Group Call Summaries
  32. CTA, Clinically Feasible Profile
  33. CTV-AD Considerations for Future Editions
  34. CT Acquisition Protocol Groundwork
  35. CT Angiography Call Summaries Archive
  36. CT Angiography Profile Draft Archive
  37. CT Draft Proffered Protocols
  38. CT Tumor Volume Change for Advanced Disease, Clinically Feasible Profile
  39. Call Agenda Topics
  40. Claim Language/Detail
  41. Clinical Applications and Biological Targets Subcommittee
  42. Clinical Sites
  43. Clinical Trial Planning
  44. Clinical Trials Collaboration
  45. Columbia University Medical Center
  46. Combined: System Dependencies & Phantom Development Subcommittees
  47. Combined Nuclear Medicine Biomarker Committee Call Summaries
  48. Committee on Image Archives
  49. Committee on Open Image Archives
  50. Consensus Process

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://qibawiki.rsna.org/index.php/Special:DeadendPages"